COVID-19 | Zydus Cadila seeks human trial approval for antibody cocktail
The Hindu
The Ahmedabad-based drug firm says the treatment candidate, ZRC-3308, was earlier shown to reduce lung damage during animal trials
India's has sought regulatory approval for clinical trials of its antibody cocktail to treat mild COVID-19, as the country grapples with a shortage of medicines and vaccines needed to effectively tackle a devastating second wave of the pandemic. The treatment candidate, ZRC-3308, was earlier shown to reduce lung damage during animal trials, the drugmaker said,adding it was found to be safe and well-tolerated.More Related News